Carl Simpson Elected to Chairman of Kerberos Proximal Solutions.Business Editors/Health/Medical Writers BIOWIRE2K MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--March 3, 2004 Kerberos Proximal Solutions is proud to announce the election of Carl J. Simpson to Chairman of the Board. Simpson brings industry experience that is unprecedented in the field of interventional medicine. "With our upcoming market launch of the Rinspiration System, Mr. Simpson's commitment, respect and vision will greatly support our endeavor to deliver needed solutions to the hands of interventionalists," said Kerberos Founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. John MacMahon. Simpson was one of the early founders and first employee of Advanced Cardiovascular Systems, which was acquired by Eli Lilly Eli Lilly can refer to:
"Kerberos has developed revolutionary technology to address the unmet clinical needs of managing vascular debris and thrombus thrombus /throm·bus/ (throm´bus) pl. throm´bi a stationary blood clot along the wall of a blood vessel, frequently causing vascular obstruction. throughout the vascular system," said Simpson. "This Rinspiration platform is a unique approach that will change the way physicians treat PVD PVD abbr. peripheral vascular disease PVD Peripheral vascular disease, see there , CAD, AMI, stroke and vein grafts. In all my interventional experience this is the second most exciting product since the development of the coronary stent coronary stent Intracoronary stent Cardiology An expandable tubular device which can be inserted percutaneously, and left within a coronary artery lumen to maintain its patency Pros Clinical and angiographic outcomes are better with intracoronary artery stent ." Kerberos Proximal Solutions, Inc. (www.kerberos-md.com), is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. delivering solutions to sites of vascular injury. Present disclosed investors include BioVentures West & Research Corporation Technologies (www.rctech.com). Contact: John MacMahon President & CEO Kerberos Proximal Solutions, Inc. 1400 Terra Bella Avenue Mountain View, CA 94043 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion